港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫美概念股

615.910

-2.061-0.33%

漲家數：4

跌家數：9

平家數：- -

市盈率：- -

高：629.455

開：617.017

低：610.131

收：617.971

資料載入中...

復星醫藥(02196)獲控股股東復星高科技質押3000萬股

去年和復星醫藥“分手”！這家創新藥企要再衝IPO！但虧損依舊……

換了四任保薦機構！五次備案！現在中金出馬，滬鴿IPO這回能成功嗎？

IPO日报国际金...

四環醫藥02月25日遭主力拋售182萬元

山河藥輔1月完成回購，股東2月宣佈減持，復星醫藥已累計套現超1.2億

瑞麗醫美盤中異動下午盤快速上漲6.80%

招銀國際：內地藥品價格政策有望優化醫療AI加速商業化落地

醫美狂飆50%+，創新藥管線收穫在即，解碼四環醫藥（0460.HK）的雙增長極邏輯

醫思健康盤中異動早盤股價大跌5.41%報0.700港元

郭廣昌：關於AI，未來特別看好兩個方向

聚焦創新與國際化發展，上海生物醫藥行業邁入集羣化、高質量發展新階段

瑞麗醫美盤中異動快速拉昇6.73%報0.111港元

復星醫藥再出手！頻頻減持山河藥輔累計套現逾1.2億元

读创客户端

山河藥輔：股東擬減持不超過3%公司股份

中国财富网

復鋭醫療科技盤中異動快速跳水5.26%報3.600港元

山河藥輔：股東復星醫藥因經營需要擬減持不超過3%公司股份

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1593/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":615.91016,"timestamp":1741334919528,"preClose":617.97076,"halted":0,"volume":98237105,"delay":0,"changeRate":-0.003334,"change":-2.060608,"pbRate":1.190795,"amount":537677282,"amplitude":0.031271,"prevYearClose":571.87146,"fiveDayClose":612.07,"twentyDayClose":570.981,"turnoverRate":0.004789,"marketCap":111057548872,"floatMarketCap":73073330248,"peRate":21.56404},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":629.45526,"amplitude":0.031271,"preClose":617.97076,"low":610.1307,"pbRate":"1.190795","latestPrice":615.91016,"volume":98237105,"delay":0,"open":617.01715,"prevYearClose":571.87146,"prevWeekClose":615.91,"prevMonthClose":612.07,"prevQuarterClose":571.871,"fiveDayClose":612.07,"twentyDayClose":570.981,"sixtyDayClose":575.728,"secType":"PLATE","market":"HK","turnoverRate":0.004789,"peRate":21.56404,"marketCap":111057548872,"floatMarketCap":73073330248,"timestamp":1741334919528,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":4,"down":9,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:16,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514984060","title":"復星醫藥(02196)獲控股股東復星高科技質押3000萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514984060","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514984060?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 19:45","pubTimestamp":1740483900,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，公司于2025年2月25日接到控股股东上海复星高科技(集团)有限公司(简称“复星高科技”)的通知，其已将所持有公司的部分A股股份办理质押手续，本次质押股份数量为3000万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK1191","BK1515","BK0060","BK0096","BK1593","02196","BK0175","BK0187","BK0188","BK0239","600196","BK0012","BK0183","BK0196"],"gpt_icon":0},{"id":"2514067150","title":"去年和復星醫藥“分手”！這家創新藥企要再衝IPO！但虧損依舊……","url":"https://stock-news.laohu8.com/highlight/detail?id=2514067150","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514067150?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 19:15","pubTimestamp":1740482100,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　时隔两年半，真实生物科技有限公司再次向港交所申请主板上市。　　此前，真实生物的产品阿兹夫定于2022年7月附条件获批，成为首款获批上市的国产新冠肺炎口服药物。　　紧接着，获批十天后，真实生物于2022年8月4日首次向港交所递交了招股书，引发市场巨大关注。但是，真实生物的首次赴港路却以失败告终。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2025-02-25/doc-inemtccz1114606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK0096","06978","BK0183","02196","BK0012","BK0187","BK1593","BK0175","BK0060","BK0188","159992","BK1161","BK1515","BK0196","BK0239","BK0028","600196","BK1574"],"gpt_icon":0},{"id":"2514060442","title":"換了四任保薦機構！五次備案！現在中金出馬，滬鴿IPO這回能成功嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514060442","media":"IPO日报国际金...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514060442?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 19:15","pubTimestamp":1740482100,"startTime":"0","endTime":"0","summary":"2021年12月，沪鸽申请创业板IPO受理，接受一轮问询，随后又于2022年8月申请终止上市。2022年9月，沪鸽上市辅导再次进行了备案，辅导机构为中原证券，随后则因撤回辅导备案而终止。自此，历经六年，沪鸽频繁更换四任保荐券商，接受了五次上市辅导备案，但连A股上市的龙门都没有见到。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-02-25/doc-inemtcea8841827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1587","BK1583","BK1593","159982","06699","399300"],"gpt_icon":0},{"id":"2514507510","title":"四環醫藥02月25日遭主力拋售182萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514507510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514507510?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 16:17","pubTimestamp":1740471429,"startTime":"0","endTime":"0","summary":"02月25日, 四环医药股价跌4.84%，报收0.59元，成交金额751万元，换手率0.13%，振幅4.84%，量比0.57。四环医药今日主力资金净流出182万元，连续7日净流出，上一交易日主力净流出28万元。该股近5个交易日下跌3.28%，主力资金累计净流出411万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入644万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225165009abdc1eee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225165009abdc1eee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","00460","BK1593","BK1600"],"gpt_icon":0},{"id":"2514051893","title":"山河藥輔1月完成回購，股東2月宣佈減持，復星醫藥已累計套現超1.2億","url":"https://stock-news.laohu8.com/highlight/detail?id=2514051893","media":"时代周报","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514051893?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 15:45","pubTimestamp":1740469516,"startTime":"0","endTime":"0","summary":"作者：梁怡山河药辅（300542.SZ）再遭股东复星医药（600196.SH）减持。2月24日，山河药辅公告，股东上海复星医药产业发展有限公司（以下简称：复星产业）因经营需要，计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股，即不超过公司总股本的3%。复星产业是复星医药的全资子公司，主要从事医药企业的股权投资等业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502253328956490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","02196","BK1191","BK1515"],"gpt_icon":0},{"id":"2514034798","title":"瑞麗醫美盤中異動 下午盤快速上漲6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514034798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514034798?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 13:41","pubTimestamp":1740462089,"startTime":"0","endTime":"0","summary":"2025年02月25日下午盘13时41分，瑞丽医美股票出现波动，股价大幅上涨6.80%。截至发稿，该股报0.110港元/股，成交量125.267万股，换手率0.22%，振幅6.80%。瑞丽医美股票所在的医疗及医学美容服务行业中，整体跌幅为1.00%。其相关个股中，现代健康科技、瑞丽医美、天元医疗涨幅较大，振幅较大的相关个股有天元医疗、现代健康科技、一脉阳光，振幅分别为57.69%、16.05%、12.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251341299891c177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251341299891c177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02135","BK1593","BK1209"],"gpt_icon":0},{"id":"2514129084","title":"招銀國際：內地藥品價格政策有望優化 醫療AI加速商業化落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2514129084","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514129084?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 09:50","pubTimestamp":1740448233,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，维持内地医药行业“优于大市评级”。MSCI中国医疗指数2025年初至今累计上涨11.5%，跑输MSCI中国指数1.2%。受益于国内药品价格政策优化、国内宏观环境改善以及海外降息预期，医药行业有望在2025年继续迎来估值修复。报告指，丙类医保目录年内即将落地，创新药将覆盖获得更好的支付环境；医疗设备招标加速复苏，将推动国产医疗设备企业盈利复苏。该行看好行业估值修复，推荐买入信达生物(01801)、百济神州(06160)、三生制药(01530)、联影医疗(688271.SH)、巨子生物(02367)、药明康德(02359)、科伦博泰生物-B(06990)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","BK1576","LU0588546209.SGD","02359","BK1141","LU2488822045.USD","LU1046422090.SGD","BK1593","01801","LU2125910500.SGD","LU0320764599.SGD","BK1161","01530","BK1500","BK1589","LU0708995583.HKD","150261","LU2242644610.SGD","BK1583","BK1588","LU2045819591.USD","02367","LU0052750758.USD","LU0307460666.USD","BK1207","06160","LU1969619763.USD"],"gpt_icon":0},{"id":"2514846290","title":"醫美狂飆50%+，創新藥管線收穫在即，解碼四環醫藥（0460.HK）的雙增長極邏輯","url":"https://stock-news.laohu8.com/highlight/detail?id=2514846290","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514846290?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 09:42","pubTimestamp":1740447738,"startTime":"0","endTime":"0","summary":"2024年公司医美板块收入增速保持不低于50%。","market":"us","thumbnail":"https://img7.gelonghui.com/column/6.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/6.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1805447","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","BK1191","00460","06978","BK1600","BK1574","BK1515","BK1593"],"gpt_icon":0},{"id":"2514108406","title":"醫思健康盤中異動 早盤股價大跌5.41%報0.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514108406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514108406?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 09:38","pubTimestamp":1740447515,"startTime":"0","endTime":"0","summary":"2025年02月25日早盘09时38分，医思健康股票出现异动，股价快速下跌5.41%。截至发稿，该股报0.700港元/股，成交量21.5万股，换手率0.02%，振幅2.70%。资金方面，该股资金流入0港元，流出15.053万港元。医思健康股票所在的医疗及医学美容服务行业中，整体跌幅为0.68%。其相关个股中，宏力医疗管理、熙康云医院、亮晴控股涨幅较大，振幅较大的相关个股有平安好医生、希玛医疗、瑞尔集团，振幅分别为5.99%、5.50%、4.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093835962f2aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093835962f2aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1215","02138","BK1593","BK1511"],"gpt_icon":0},{"id":"2513744139","title":"郭廣昌：關於AI，未來特別看好兩個方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2513744139","media":"新京报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513744139?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 19:21","pubTimestamp":1740396060,"startTime":"0","endTime":"0","summary":"“未来，我特别看好两个方向，一是AI赋能各垂直行业进行行业的再造与升级，另一个是物理AI与虚拟AI真正结合对生产力和生产关系产生的革命性变化。”郭广昌认为，在当前环境下，找一个行业从头做起的机会越来越少，要聚集优势产业做深做透。对复星而言，未来仍然是聚焦大健康、旅文、消费等优势产业“深挖矿”，依靠产业运营能力，用“手艺活”赚钱，依靠创新和全球化，深耕国内和全球市场，全面融入AI提升效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224192222a251dabd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224192222a251dabd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600196","BK1230","BK1191","02196","00656","BK1515","BK1593"],"gpt_icon":0},{"id":"2513714095","title":"聚焦創新與國際化發展，上海生物醫藥行業邁入集羣化、高質量發展新階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2513714095","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513714095?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 16:07","pubTimestamp":1740384476,"startTime":"0","endTime":"0","summary":"此次大会的召开，标志着上海生物医药行业将不断迈入集群化、高质量发展新阶段。陈启宇会长在任职演讲中表示，成立上海市工商联生物医药商会不仅是上海生物医药行业的里程碑，更是推动行业高质量发展的新起点。上海已汇聚一大批优秀的民营生物医药企业，创新与国际化发展大有可为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022416061398908903&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022416061398908903&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","02196","600196","BK1593"],"gpt_icon":0},{"id":"2513147798","title":"瑞麗醫美盤中異動 快速拉昇6.73%報0.111港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513147798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513147798?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:41","pubTimestamp":1740361306,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时41分，瑞丽医美股票出现波动，股价大幅上涨6.73%。截至发稿，该股报0.111港元/股，成交量10万股，换手率0.02%，振幅6.73%。资金方面，该股资金流入8320港元，流出0港元。瑞丽医美股票所在的医疗及医学美容服务行业中，整体涨幅为0.05%。其相关个股中，瑞丽医美、脑动极光-B、固生堂涨幅较大，振幅较大的相关个股有健康之路、讯飞医疗科技、瑞丽医美，振幅分别为16.00%、10.65%、6.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022409414698902e65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022409414698902e65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1209","BK1593","02135"],"gpt_icon":0},{"id":"2513798794","title":"復星醫藥再出手！頻頻減持山河藥輔 累計套現逾1.2億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513798794","media":"读创客户端","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513798794?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:41","pubTimestamp":1740361299,"startTime":"0","endTime":"0","summary":"山河药辅表示，复星医药拟减持时间为2025年3月18日至6月15日，拟减持价格根据减持时市场价格及相关规定确定，不低于发行价。目前，复星医药持有山河药辅2392.81万股，占该公司总股本比例为10.20%，为其第二大股东。近年来，复星医药多次出手减持。以此计算，复星医药套现约2770.27万元。另据iFind数据统计，2018年—2020年，复星医药7次减持山河药辅，累计套现约9800万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224095519962dd60c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224095519962dd60c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","BK1515","BK1593"],"gpt_icon":0},{"id":"2513601267","title":"山河藥輔：股東擬減持不超過3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513601267","media":"中国财富网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513601267?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:33","pubTimestamp":1740360832,"startTime":"0","endTime":"0","summary":"根据公告，复星医药目前持有山河药辅股份23,928,059股，占公司总股本的10.20%。此次减持计划涉及不超过6,978,000股，占公司总股本的3%。复星医药表示，此次减持的主要原因是根据其自身经营需要，获取投资收益。公告还提到，复星医药在山河药辅首次公开发行时的股份锁定和减持承诺已履行完毕，未出现违反承诺的行为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224094444a2513e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224094444a2513e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1593","BK1515","BK1191"],"gpt_icon":0},{"id":"2513760811","title":"復鋭醫療科技盤中異動 快速跳水5.26%報3.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513760811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513760811?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 09:30","pubTimestamp":1740360634,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时30分，复锐医疗科技股票出现异动，股价急速跳水5.26%。截至发稿，该股报3.600港元/股，成交量12.28万股，换手率0.03%，振幅5.00%。资金方面，该股资金流入8904港元，流出40.3096万港元。复锐医疗科技股票所在的医疗设备及用品行业中，整体涨幅为0.05%。其相关个股中，先瑞达医疗-B、心通医疗-B、微泰医疗-B涨幅较大，振幅较大的相关个股有复锐医疗科技、堃博医疗-B、爱康医疗，振幅分别为5.00%、3.66%、3.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093034989029f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224093034989029f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1585","BK1100","01696"],"gpt_icon":0},{"id":"2513759975","title":"山河藥輔：股東復星醫藥因經營需要擬減持不超過3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513759975","media":"观点网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513759975?lang=zh_tw&edition=fundamental","pubTime":"2025-02-23 23:11","pubTimestamp":1740323511,"startTime":"0","endTime":"0","summary":"观点网讯：山河药辅2月23日公告，股东上海复星医药产业发展有限公司因经营需要，计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股，即不超过公司总股本的3%。 山河药辅表示，公司生产经营情况正常。本次拟减持股份的股东不属于公司的控股股东或实际控制人，本次股份减持不会导致公司控制权发生变更，不会对公司治理结构、股权结构及持续性经营产生影响。免责声明：本文内容与数据由观点根据公开信息整理，不构成投资建议，使用前请核实。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/23231148332588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK0187","BK1593","BK0060","BK1191","BK0196","BK0175","BK0096","600196","300452","BK0012","BK0183","BK0239","BK0188","BK0028","BK0177","02196"],"gpt_icon":0}],"pageSize":16,"totalPage":9,"pageCount":8,"totalSize":131}]}}